发布于: 公告转发:1回复:1喜欢:0
$德纳维制药(DVAX)$ 8-K - Current report Filed: 2018-02-20 AccNo: 0001193125-18-050501 Size: 50 KBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a RegistrantItem 3.03: Material M 网页链接

全部讨论

2018-02-21 16:43

支持乙肝疫苗销售和抗癌药物临床开发